Look for:

Our offer for

REGENERON PHARMACEUTICALS INC.


ISIN:
US75886F1075
WKN:
75886F107
2022/05/27 08:02:58
Price
636.70 EUR
Difference -0.92% (-5.90)

General attributes

ISINUS75886F1075
SymbolREGN
ExchangeMunich
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)69,740 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)-
Ask (Ask size)-
Open636.70 EUR
High636.70 EUR
Low636.70 EUR
Close (prev. day)642.60 EUR
VWAP619.00 EUR
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: REGENERON PHARMACEUTICALS INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/05/27 08:02:58
Price
636.70 EUR
Difference -0.92% (-5.90)

General attributes

ISINUS75886F1075
SymbolREGN
ExchangeMunich
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)69,740 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)-
Ask (Ask size)-
Open636.70 EUR
High636.70 EUR
Low636.70 EUR
Close (prev. day)642.60 EUR
VWAP619.00 EUR
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Performance and Risk

6m1Y3Y
Perf (%)+14.71%+56.71%+126.59%
Perf (abs.)+82.40+232.55+359.00
Beta0.530.540.58
Volatility24.4324.9234.09
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)632.78 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)628.98 EUR (2)
Ø price 100 days | Ø volume 100 days (pcs.)588.93 EUR (2)
Ø price 250 days | Ø volume 250 days (pcs.)548.86 EUR (8)
YTD High | date673.70 EUR (2022/04/11)
YTD Low | date526.00 EUR (2022/02/22)
52 Weeks High | date673.70 EUR (2022/04/11)
52 Weeks Low | date410.05 EUR (2021/05/27)

All listings for REGENERON PHARMACEUTICALS INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Berlin2022/05/2708:03629.60 EUR0.001
Duesseldorf2022/05/2719:31641.60 EUR0.0012
Frankfurt2022/05/2715:46639.40 EUR0.054
Hamburg2022/05/2708:00630.90 EUR0.001
Hanover2022/05/2708:00630.90 EUR0.001
London Stock Exchange2022/05/2315:30668.04 USD0.052
Munich2022/05/2708:02636.70 EUR0.001
Nasdaq2022/05/2722:00692.80 USD385.0920,653
Stuttgart2022/05/2721:29643.80 EUR0.015
Tradegate2022/05/2722:26645.40 EUR0.0510
Vienna Stock Exchange2022/05/2717:32642.70 EUR0.013
Xetra2022/05/2717:35643.30 EUR0.1012

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=99472&ID_TYPE_IMAGE_LOGO=2

Contact Details

REGENERON PHARMACEUTICALS INC.
- -
777 Old Saw Mill River Road - 10591-6707 Tarrytown
Telefon: 1-914-847-7000
Fax: -
E-mail: -

PDF Downloads

Company report: REGENERON PHARMACEUTICALS INC.PDF Download

Company Profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Members of Management Board

P. VagelosChairman of Board of Directors
Bonnie BasslerMember of Board of Directors
George YancopoulosMember of Board of Directors
Huda ZoghbiMember of Board of Directors
Joseph GoldsteinMember of Board of Directors
Marc Tessier-LavigneMember of Board of Directors
Michael BrownMember of Board of Directors
N. ColesMember of Board of Directors
Arthur RyanMember of Board of Directors
Christine PoonMember of Board of Directors
George SingMember of Board of Directors
Leonard S. SchleiferChairman of Managing Board
George D. YancopoulosMember of Executive Committee
Robert E. LandryMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer